Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre ...

The maker of Advil, Tums and Sensodyne toothpaste is investing $54.2 million to upgrade its global research and development ...

Haleon, a global company behind home healthcare products like Advil, Tums and Aquafresh, announced plans to upgrade its Richmond research and development facility.

Haleon's global business lead for the Pain Portfolio & Systemics shares key consumer health trends reshaping the healthcare ...

The execs at Haleon, a huge multinational consumer products company, ought to take a good look in the mirror. That is, unless misleading, sleazy marketing is in the mission statement. In that case, ...

Haleon PLC closed 5.73% below its 52-week high of £4.01, which the company reached on September 18th.

The consumer health company site will launch an internship program with the state government and Virginia Commonwealth ...

The UK-based pharmaceutical company Haleon will invest $54.2 million to upgrade its R&D facility in Richmond, which has ...

Richmond is cementing its status as a hub for pharmaceutical innovation, with Gov. Glenn Youngkin dubbing the region a ...

This comprehensive health news roundup highlights a tragic diphtheria case in Germany, vaccine and abortion-related scrutiny ...

Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre ...

Haleon PLC HLN shares inched up 0.94% to £3.75 Monday, on what proved to be an all-around great trading session for the stock ...